|
TBL1XR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.42470004869256E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.790710E-04 |
| Normal-vs-Stage2 |
4.840800E-03 |
| Normal-vs-Stage3 |
6.457700E-03 |
| Normal-vs-Stage4 |
1.912450E-02 |
| Stage1-vs-Stage2 |
2.748400E-01 |
| Stage1-vs-Stage3 |
1.631200E-01 |
| Stage1-vs-Stage4 |
8.511900E-02 |
| Stage2-vs-Stage3 |
5.916200E-01 |
| Stage2-vs-Stage4 |
1.980990E-01 |
| Stage3-vs-Stage4 |
3.375400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.83519999699777E-08 |
| Normal-vs-AfricanAmerican |
5.641100E-04 |
| Normal-vs-Asian |
3.553600E-01 |
| Caucasian-vs-AfricanAmerican |
3.900600E-01 |
| Caucasian-vs-Asian |
2.993600E-01 |
| AfricanAmerican-vs-Asian |
4.100400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.40789999845271E-08 |
| Normal-vs-Female |
1.7054799999916E-05 |
| Male-vs-Female |
2.434200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.282900E-03 |
| Normal-vs-Extreme_Weight |
3.603100E-04 |
| Normal-vs-Obese |
1.9071499999912E-05 |
| Normal-vs-Extreme_Obese |
2.551800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.542800E-01 |
| Normal_Weight-vs-Obese |
3.432000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.402600E-01 |
| Extreme_Weight-vs-Obese |
8.646000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.786200E-01 |
| Obese-vs-Extreme_Obese |
4.519200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.195870E-02 |
| Normal-vs-Age(41-60Yrs) |
6.12829997859166E-09 |
| Normal-vs-Age(61-80Yrs) |
7.54630000000533E-05 |
| Normal-vs-Age(81-100Yrs) |
6.953700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.740800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.635800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.940300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.282100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.247560E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.779200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.54159995879866E-09 |
| Normal-VS-Type2 PRCC |
6.426400E-02 |
| Normal-VS-KIRP CIMP |
4.844400E-03 |
| Normal-VS-Unclassified PRCC |
9.443100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.639900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.668000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.266800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.155600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.771640E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.246500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.341700E-02 |
| Normal-vs-N1 |
4.553200E-04 |
| Normal-vs-N2 |
7.606200E-02 |
| N0-vs-N1 |
5.315800E-03 |
| N0-vs-N2 |
1.017570E-01 |
| N1-vs-N2 |
1.759230E-01 |
|
|
